Workflow
Molecular residual disease (MRD) testing
icon
Search documents
Here's Why Exact Sciences (EXAS) is a Strong Momentum Stock
ZACKS· 2025-10-09 14:50
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor.It also includes access to the Zacks Style Scores. What are the Zacks Style Scores? The Zacks Style Sco ...
Why Exact Sciences (EXAS) is a Top Momentum Stock for the Long-Term
ZACKS· 2025-09-22 14:51
Core Viewpoint - Zacks Premium provides various tools and resources to help investors make informed decisions and enhance their investment strategies Investment Tools and Features - Zacks Premium includes daily updates of the Zacks Rank and Zacks Industry Rank, access to the Zacks 1 Rank List, Equity Research reports, and Premium stock screens [1] - The service also offers Zacks Style Scores, which are designed to assist investors in selecting stocks with the highest potential to outperform the market in the short term [2] Zacks Style Scores - The Zacks Style Scores rate stocks using an alphabetic system (A, B, C, D, F) based on value, growth, and momentum characteristics, with A being the highest rating [3] - The Style Scores are categorized into four types: Value Score, Growth Score, Momentum Score, and VGM Score [3][4][5][6] Value Score - Focuses on identifying undervalued stocks using financial ratios such as P/E, PEG, Price/Sales, and Price/Cash Flow [3] Growth Score - Evaluates a company's financial health and future growth potential by analyzing projected and historical earnings, sales, and cash flow [4] Momentum Score - Targets stocks experiencing upward or downward trends in price or earnings, utilizing factors like one-week price change and monthly earnings estimate changes [5] VGM Score - Combines all three Style Scores to provide a comprehensive rating based on value, growth, and momentum [6] Zacks Rank - The Zacks Rank is a proprietary model that leverages earnings estimate revisions to help investors build successful portfolios [7] - Stocks rated 1 (Strong Buy) have historically achieved an average annual return of +23.64% since 1988, significantly outperforming the S&P 500 [7] Stock Selection Strategy - Investors are encouraged to select stocks with a Zacks Rank of 1 or 2 that also have Style Scores of A or B to maximize potential returns [9] - Stocks with lower ranks, even if they have high Style Scores, may still face downward price pressure due to negative earnings outlooks [10] Company Spotlight: Exact Sciences (EXAS) - Exact Sciences Corporation specializes in molecular diagnostics for early cancer detection, focusing on colorectal cancer screening, molecular residual disease testing, and multi-cancer screening [11] - EXAS holds a Zacks Rank of 3 (Hold) with a VGM Score of A and a Momentum Style Score of A, having seen a 12.3% increase in shares over the past four weeks [11][12] - Recent earnings estimates for fiscal 2025 have been revised upward, with the Zacks Consensus Estimate increasing by $0.20 to $0.36 per share, and the company has an average earnings surprise of +329.9% [12]
Here's Why Exact Sciences (EXAS) is a Strong Growth Stock
ZACKS· 2025-08-11 14:46
Core Insights - Zacks Premium offers various tools for investors to enhance their stock market engagement and confidence [1] - The Zacks Style Scores are designed to help investors identify stocks with the highest potential to outperform the market in the short term [2] Zacks Style Scores Overview - The Style Scores consist of four categories: Value Score, Growth Score, Momentum Score, and VGM Score, each focusing on different investment strategies [3][4][5][6] - Value Score emphasizes identifying undervalued stocks using financial ratios [3] - Growth Score focuses on a company's financial health and future growth potential [4] - Momentum Score identifies trends in stock prices and earnings estimates to optimize entry points [5] - VGM Score combines all three styles to highlight stocks with the best overall characteristics [6] Zacks Rank and Style Scores Interaction - The Zacks Rank utilizes earnings estimate revisions to guide investors in stock selection, with 1 (Strong Buy) stocks historically yielding an average annual return of +23.75% since 1988 [7] - The combination of Zacks Rank and Style Scores helps investors narrow down their choices among numerous top-rated stocks [8] - Stocks with a Zacks Rank of 1 or 2 and Style Scores of A or B are recommended for maximizing returns [9] Company Spotlight: Exact Sciences (EXAS) - Exact Sciences Corporation specializes in molecular diagnostics for early cancer detection, focusing on colorectal cancer screening, molecular residual disease testing, and multi-cancer screening [11] - EXAS holds a Zacks Rank of 3 (Hold) and has a VGM Score of A, indicating solid potential [11] - The company is projected to experience significant growth, with a year-over-year earnings growth forecast of 226.1% for the current fiscal year [12] - Recent analyst revisions have positively impacted earnings estimates, with an increase from $0.24 to $0.29 per share [12] - EXAS has demonstrated an impressive average earnings surprise of +329.9%, making it a strong candidate for growth investors [12][13]
Why Exact Sciences (EXAS) is a Top Growth Stock for the Long-Term
ZACKS· 2025-07-24 14:46
Core Insights - Zacks Premium offers various tools for investors to enhance their stock market engagement and confidence [1] - The Zacks Style Scores are designed to complement the Zacks Rank, aiding investors in selecting stocks likely to outperform the market in the short term [2] Zacks Style Scores Overview - Stocks are rated from A to F based on value, growth, and momentum characteristics, with A being the highest score [3] - The Style Scores are categorized into four types: Value Score, Growth Score, Momentum Score, and VGM Score [3][4][5][6] Value Score - Focuses on identifying undervalued stocks using financial ratios such as P/E, PEG, and Price/Sales [3] Growth Score - Evaluates a company's financial health and future potential through projected earnings and sales growth [4] Momentum Score - Targets stocks with upward or downward price trends, utilizing recent price changes and earnings estimate shifts [5] VGM Score - Combines the three Style Scores to identify stocks with the best overall value, growth, and momentum [6] Zacks Rank Integration - The Zacks Rank leverages earnings estimate revisions to guide investors in building successful portfolios [7] - Stocks rated 1 (Strong Buy) have historically outperformed the S&P 500, with an average annual return of +23.62% since 1988 [8] Stock Selection Strategy - For optimal returns, investors should focus on stocks with a Zacks Rank of 1 or 2 and Style Scores of A or B [10] - Stocks with lower ranks but high Style Scores may still present risks due to declining earnings forecasts [11] Company Spotlight: Exact Sciences (EXAS) - Exact Sciences is a molecular diagnostics firm specializing in cancer detection and prevention, focusing on colorectal cancer screening and multi-cancer tests [12] - The company holds a Zacks Rank of 2 (Buy) and a VGM Score of B, indicating strong potential [12] - Forecasts suggest a remarkable year-over-year earnings growth of 169.6% for the current fiscal year, with a recent upward revision in earnings estimates [13]